To evaluate for potential applicability of our findings in the clinical setting, we characterized cholestatic liver disease-related changes in ADAM17 protein expression in liver biopsies obtained from patients with PBC and PSC. Here, ADAM17 is linked to pancreatic serous cystadenoma.